Results from a retrospective analysis of contemporary data presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism, predict, based on estimates from a multivariate regression model, that the cumulative use of anti-tumour necrosis factor drugs (anti-TNFs) for one, two, or three years is associated with reduced risk of cardiovascular events by 24%, 42% and 56% in patients with rheumatoid arthritis (RA) respectively, compared to not using anti-TNF therapies (adjusting for background use of methotrexate or other disease modifying anti-rheumatic drugs [DMARDs])...
Fonte: healthnews.com
Indique esta NotÃcia
Compartilhar
A PHP Error was encountered
Severity: User Warning
Message: Smarty error: unable to read resource: "indiquemat_healthnews.tpl"
Filename: libs/Smarty.class.php
Line Number: 1095
